HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Osteofibrous dysplasia — Clinical Guidelines

Overview

Osteofibrous dysplasia (OFD) is a rare, benign fibro-osseous lesion predominantly affecting the tibia in children and adolescents. This condition often manifests as a progressive lesion leading to bowing of the tibia and potential complications such as delayed fracture healing and pain. Due to its benign nature, OFD is not immediately life-threatening, but it can significantly impact a patient's quality of life and mobility. Early intervention is crucial to prevent deformity and functional impairment, making accurate diagnosis and timely treatment essential in day-to-day clinical practice 1 3.

Pathophysiology

Osteofibrous dysplasia arises from abnormal proliferation of fibrous and osseous tissues within the metaphyseal-diaphyseal region of long bones, particularly the tibia. The molecular basis often involves gain-of-function mutations in the MET gene, which encodes the receptor tyrosine kinase c-Met. These mutations disrupt normal signaling pathways crucial for osteoblast differentiation and bone formation, leading to impaired bone repair and delayed fracture healing 2. The resultant lesion is characterized by a mixture of fibrous tissue and immature bone, which can progressively expand and cause structural deformities. The dysregulation in MET signaling interferes with the balance between osteoblast activity and osteoclast function, contributing to the characteristic fibro-osseous matrix formation and potential recurrence after surgical intervention 2.

Epidemiology

Osteofibrous dysplasia predominantly affects children and adolescents, with a peak incidence between 5 and 15 years of age. It is more commonly observed in males, although both sexes can be affected. The condition is globally distributed but lacks specific geographic clustering, suggesting no particular environmental or genetic predisposition beyond the MET gene mutations. Incidence data are limited, but studies suggest it is relatively rare, with sporadic case reports and small series contributing to our understanding. Trends over time indicate no significant increase in incidence, but improved diagnostic imaging has likely led to earlier detection and reporting 1 2.

Clinical Presentation

Patients with osteofibrous dysplasia typically present with localized pain, swelling, and sometimes deformity of the affected tibia. Bowing of the tibia is a common finding, often leading to gait abnormalities and functional limitations. Asymptomatic cases may be identified incidentally through imaging for other reasons. Red-flag features include rapid progression of symptoms, severe pain, and signs of pathological fracture, which necessitate prompt evaluation and intervention 1.

Diagnosis

The diagnosis of osteofibrous dysplasia involves a combination of clinical assessment and imaging studies. Key diagnostic criteria include:

Clinical History and Physical Examination: Focus on age, symptoms (pain, swelling), and physical signs of deformity or gait abnormalities.

Imaging Studies:

- X-rays: Characteristic findings include a mixed radiolucent and radiopaque lesion with a "soap-bubble" appearance and cortical thickening. - MRI: Useful for assessing the extent of the lesion and distinguishing it from other lesions like osteosarcoma. - CT Scan: Provides detailed bone architecture and helps in planning surgical interventions.

Histopathology: Confirmation through biopsy showing the fibro-osseous nature of the lesion with immature bone and fibrous tissue.

Differential Diagnosis:

- Osteosarcoma: Typically shows more aggressive features on imaging and lacks the characteristic "soap-bubble" appearance. - Fibrous Dysplasia: Often involves multiple bones and lacks the specific tibial predilection seen in OFD. - Non-ossifying Fibroma: Usually smaller, more superficial lesions without cortical involvement 1 3.

Management

Surgical Interventions

#### First-Line Treatment

Subperiosteal Hemicortical Resection with Bone Grafting:

- Procedure: Removal of the lesion with subperiosteal resection, followed by autogenous bone grafting to fill the defect. - Indications: Lesions causing significant deformity or functional impairment. - Monitoring: Postoperative imaging to assess graft incorporation and recurrence. - Recurrence Management: Repeat surgical intervention if recurrence occurs, with a second procedure often effective in preventing further recurrence 1.

#### Second-Line Treatment

Marginal Excision with Ilizarov Hemicallotasis:

- Procedure: Excision of the anterior portion containing the lesion, sparing the posterior cortex, followed by distraction osteogenesis. - Indications: Lesions suitable for conservative resection and deformity correction. - Monitoring: Regular follow-up to ensure proper bone consolidation and alignment correction. - Contraindications: Extensive lesions that may not be amenable to this technique 3.

Non-Surgical Management

Observation: For asymptomatic or minimally symptomatic cases, regular clinical and imaging follow-up may be sufficient.

Pain Management: Symptomatic relief with analgesics as needed.

Complications

Recurrence: Postoperative recurrence is a significant concern, necessitating close monitoring and potential repeat surgery.

Deformity: Persistent or worsening bowing of the tibia can lead to functional limitations.

Pathological Fracture: Delayed healing and weakened bone structure increase the risk of fractures.

Referral Triggers: Persistent pain, rapid lesion progression, or suspicion of recurrence should prompt referral to orthopedic specialists for further evaluation and intervention 1.

Prognosis & Follow-up

The prognosis for patients with osteofibrous dysplasia is generally good with appropriate management, though recurrence remains a notable risk. Prognostic indicators include the extent of initial lesion involvement, surgical technique efficacy, and postoperative adherence to follow-up protocols. Recommended follow-up intervals typically include:

Imaging: Every 6-12 months initially, tapering to annually if stable.

Clinical Assessment: Regular evaluations to monitor symptoms and functional status.

Functional Outcomes: Utilizing scores like the Musculoskeletal Tumor Society (MSTS) to assess recovery and quality of life 1.

Special Populations

Pediatrics

Management in children requires careful consideration of growth dynamics and the potential impact on limb development. Conservative approaches and minimally invasive techniques are often preferred to preserve bone integrity and function.

Comorbidities

Patients with underlying metabolic bone disorders or those undergoing concurrent treatments (e.g., chemotherapy) may require tailored management strategies to address additional risks and complications 1.

Key Recommendations

Surgical Resection with Bone Grafting: For symptomatic tibial OFD, subperiosteal hemicortical resection followed by autogenous bone grafting is recommended to reduce recurrence rates (Evidence: Strong 1).

Regular Follow-Up Imaging: Postoperative imaging every 6-12 months to monitor for recurrence and graft incorporation (Evidence: Moderate 1).

Consider Marginal Excision with Distraction Osteogenesis: For suitable cases, this technique can effectively manage deformity and preserve bone structure (Evidence: Moderate 3).

Histopathological Confirmation: Essential for definitive diagnosis, distinguishing OFD from other fibro-osseous lesions (Evidence: Strong 1 3).

Pain Management and Symptomatic Relief: Provide adequate analgesia to improve patient comfort and functional outcomes (Evidence: Expert opinion).

Monitor for Recurrence and Deformity: Early intervention is crucial if signs of recurrence or worsening deformity are noted (Evidence: Moderate 1).

Pediatric Considerations: Tailor surgical approaches to minimize impact on growth and development (Evidence: Expert opinion).

Multidisciplinary Approach: Collaboration with orthopedic specialists and possibly geneticists for comprehensive care (Evidence: Expert opinion).

Functional Outcome Assessment: Use validated scores like MSTS to evaluate long-term outcomes (Evidence: Moderate 1).

Referral for Complex Cases: Prompt referral to specialized centers for refractory cases or those with atypical presentations (Evidence: Expert opinion).

References

1 Li X, Su Y. Evaluation of subperiosteal hemicortical resection and bone grafting to treat tibial osteofibrous dysplasia in children. Journal of pediatric orthopedics. Part B 2025. link 2 Hong G, Xie W, Ahmed K, Oborn C, Soltys CL, Kannu P. A genetic mouse model mimicking MET related human osteofibrous dysplasia is characterized by delays in fracture repair and defective osteogenesis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024. link 3 Kosuge DD, Pugh H, Ramachandran M, Barry M, Timms A. Marginal excision and Ilizarov hemicallotasis for osteofibrous dysplasia of the tibia: a case report. Journal of pediatric orthopedics. Part B 2011. link

Osteofibrous dysplasia